Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Koselugoinhibits tumor cell proliferation by inhibiting MEK protein activity, bl···【more】
Release date：2024-08-23Recommended：284
Koselugo is a targeted therapy drug primarily used to treat a specific subtype o···【more】
Release date：2024-08-23Recommended：317
Alpelisib is a drug for the treatment of HR/HER2- breast cancer, especially for ···【more】
Release date：2024-08-22Recommended：299
Alpelisib for the treatment of PIK3CA-mutated HR/HER2- advanced breast cancer in···【more】
Release date：2024-08-22Recommended：287
Alpelisib, approved in combination with fulvestrant in 2019 for the treatment of···【more】
Release date：2024-08-22Recommended：313
Anamorelin is a ghrelin receptor agonist used to treat cancer cachexia and signi···【more】
Release date：2024-08-22Recommended：254
Anamorelin is currently the only effective therapeutic drug that promotes appeti···【more】
Release date：2024-08-22Recommended：251
Koselugois a precision small molecule MEK blocker engineered for specific tumors···【more】
Release date：2024-08-22Recommended：280
Anamorelin is a ghrelin receptor agonist launched in Japan that brings a new tre···【more】
Release date：2024-08-22Recommended：276
Koselugois a precision small molecule MEK inhibitor designed for specific tumor ···【more】
Release date：2024-08-22Recommended：342
Koselugo is a carefully developed small molecule MEK blocker (also known as a mi···【more】
Release date：2024-08-22Recommended：328
As the world's first drug specifically for the treatment of cachexia, Anamor···【more】
Release date：2024-08-22Recommended：250
